BeStock  
Stocks › Biotechnology › SLS

Sellas Life Sciences SLS

US equityMarket cap rank #2495Biotechnology
$13.66 −$1.20 (-8.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.21 +4.03%
Open$14.98
Prev close$14.86
Day range$13.39 – $15.19
Volume15.48M
Market cap$2.78B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts1
Average target$30.00+119.6% vs. price
  • Buy 100%

Recent rating changes

The last 16 actions on file set price targets from $7.00 to $30.00, averaging $16.47.

DateFirmRatingTarget
13 Nov 2026 Maxim Group BUY $30.00
28 Oct 2026 Maxim Group BUY $30.00
19 Aug 2026 Maxim Group BUY $30.00
12 Aug 2026 Maxim Group BUY $30.00
8 Jul 2026 Maxim Group BUY $30.00
6 Jul 2026 A. G. P. BUY $25.00
14 May 2026 Maxim Group BUY $10.00
13 May 2026 Maxim Group BUY $10.00
20 Mar 2026 A. G. P. BUY $10.00
20 Mar 2026 Maxim Group BUY $10.00
13 Mar 2026 Maxim Group BUY $10.00
12 Mar 2026 Maxim Group BUY $10.00
29 Dec 2025 Maxim Group BUY $7.00
17 Nov 2025 A. G. P. BUY $7.50
13 Nov 2025 Maxim Group BUY $7.00
3 Nov 2025 Maxim Group BUY $7.00

Discussion

No comments yet — be the first to weigh in on SLS.

Sign in to join the discussion.

Scroll to Top